Arrowstreet Capital’s Safeguard Scientifics, Inc. SFE Stock Holding History

Arrowstreet Capital’s Portfolio SFE Stock Details SFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-36,140	Closed	-$189K	–	1474
2022 Q1	$189K	Sell	36,140 -40,781	-53%	-$247K	﹤0.01%	1119
2021 Q4	$565K	Sell	76,921 -99,779	-56%	-$779K	﹤0.01%	1266
2021 Q3	$1.57M	Sell	176,700 -11,024	-6%	-$88.3K	﹤0.01%	1189
2021 Q2	$1.46M	Buy	187,724 +35,793	+24%	+$244K	﹤0.01%	1435
2021 Q1	$1.04M	Buy	151,931 +22,498	+17%	+$163K	﹤0.01%	1778
2020 Q4	$826K	Sell	129,433 -1,700	-1%	-$10.6K	﹤0.01%	1882
2020 Q3	$719K	Hold	131,133	–	–	﹤0.01%	1909
2020 Q2	$918K	Sell	131,133 -7,739	-6%	-$49K	﹤0.01%	1795
2020 Q1	$771K	Sell	138,872 -22,337	-14%	-$200K	﹤0.01%	1398
2019 Q4	$1.77M	Buy	161,209 +92,799	+136%	+$1.06M	﹤0.01%	1175
2019 Q3	$776K	Buy	+68,410	New	+$815K	﹤0.01%	1229

Other funds holding SFE

CCM

Contrarian Capital Management Greenwich, Connecticut $357M AUM 18.27% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Clayton Partners Berkeley, California $138M AUM 38.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Arrowstreet Capital's SFE Position: Q2 2022 in Review

Arrowstreet Capital sold out of Safeguard Scientifics, Inc. (SFE) in Q2 2022, closing a stake of 36,140 shares — an estimated $189K sold.

Arrowstreet Capital first reported a position in SFE in Q3 2019 and held it in 11 quarters. The position peaked at $1.77M in Q4 2019. 48 funds tracked by Wall St. Rank hold SFE as of Q2 2022.

Arrowstreet Capital reported no remaining Safeguard Scientifics, Inc. position as of Q2 2022 after selling out during the quarter.
Arrowstreet Capital sold 36,140 Safeguard Scientifics, Inc. shares in Q2 2022, an estimated $189K.
Arrowstreet Capital first reported a position in Safeguard Scientifics, Inc. in Q3 2019 and held it in 11 quarters.
Arrowstreet Capital's Safeguard Scientifics, Inc. position peaked at $1.77M in Q4 2019.
48 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q2 2022.

Based on Arrowstreet Capital's 13F filing for Q2 2022, filed 15 Aug 2022.